Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data

NCT06392763 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT06392763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06392763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
August 3, 2021
Completion date
April 28, 2023
Enrollment
602 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia (all), diffuse large b-cell lymphoma